Objective 1: Integrated Disease Management Efficacy and Economic Viability
1a. High- vs. Low-Intensity Management Trials
We will run three-year, multi-site field trials comparing “high-intensity” strategies (e.g., multiple fungicide applications, seed treatments, and manipulating maturity groups) against minimal or no treatment. Each site’s yield, disease incidence, and associated costs will be tracked to determine the conditions under which each management intensity optimizes ROI. By doing so, we aim to offer farmers tailored recommendations for profitable, environment-specific disease management.
1b. Uniform Fungicide Trials
Building on established efficacy protocols, participating co-PIs will annually evaluate new and existing fungicide products across multiple environments. These data will inform regional updates to fungicide efficacy tables and provide a robust foundation for practical recommendations. In addition, the uniform approach will help pinpoint product performance under emerging disease challenges.
1c. Economic Analysis of Fungicide Trials
We will collect historical uniform fungicide trial results alongside new data, performing an economic meta-analysis to map ROI across various locations and weather patterns. This effort will reveal which fungicides perform best under differing temperature, rainfall, and humidity conditions, yielding environment-specific guidance. Ultimately, these findings will complement Objective 1a by identifying where intensive fungicide use is financially advantageous.
Objective 2: Biologicals Uniform Fungicide Trials
2a. Evaluating Biological Controls for White Mold
Yearly multi-location trials will pit biological fungicides against a known, highly effective chemical control and an untreated check. Researchers will gauge both disease incidence and yield, running partial profit analyses to assess cost-effectiveness. This will clarify the viability of biological products for white mold under real-world conditions.
2b & 2c. Biological Seed Treatments (Oomycetes & SDS)
We will explore the efficacy of biological seed treatments against key pathogens—Phytophthora, Pythium (2b), and Fusarium virguliforme, the causal agent of sudden death syndrome (2c). Trials will be conducted at sites either inoculated with or naturally containing these pathogens, measuring stand counts, disease severity, and yield. Each product’s profitability will be evaluated, guiding farmers on whether and when biological seed treatments make economic sense.
Objective 3: Soybean Farmer Survey
We will develop a survey aimed at understanding how farmers choose disease management tactics. This includes measuring their familiarity with fungicide modes of action, adoption of biological products, cost considerations, and perceived risks or benefits. Survey results will illuminate how economic and social factors influence on-farm decisions, steering future Extension content and possibly shaping new research directions.
Objective 4: Extension Materials and Decision Tools
4a. Development of Extension Material
Each season, participating co-PIs will compile data from their trials, leading to updated or newly created efficacy tables for both chemical fungicides and biological products. These resources will be disseminated through Extension events, digital platforms, Soybean Research Information Network (SRIN), and the Crop Protection Network (CPN), ensuring farmers and agronomists have access to the latest findings on product performance and best practices.
4b. Creation of ROI Decision Tools
Leveraging economic insights from Objective 1c, we will build and host interactive calculators for key soybean diseases—initially white mold and frogeye leaf spot. By entering product costs, grain prices, and expected yields, farmers will receive rapid estimates of likely returns. Promoted through channels like SRIN, these tools will empower farmers to compare products more effectively and bolster profitable disease management decisions.